- Title
- Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study
- Creators
- Antonio González-Martín - Spanish Ovarian Cancer Research GroupBhavana Pothuri - Gynecologic Oncology GroupIgnace Vergote - The European Academy of Gynaecological SurgeryRené Depont ChristensenWhitney Graybill - Medical University of South CarolinaMansoor Raza MirzaColleen MccormickDomenica Lorusso - Fondazione IRCCS Istituto Nazionale dei TumoriPaul Hoskins - BC Cancer AgencyGilles Freyer - Hôpital Lyon SudKlaus BaumannKris Jardon - McGill University Health CentreAndrés Redondo - Hospital Universitario La PazRichard G. MooreChristof Vulsteke - AZ Maria MiddelaresRoisin E. O CearbhaillB. Lund - Aalborg UniversityFloor Backes - The Ohio State UniversityPilar Barretina-Ginesta - University of GironaAshley F. Haggerty - University of PennsylvaniaMaria J. Rubio-Pérez - Hospital Universitario Reina SofíaMark S. ShahinGiorgia Mangili - San Raffaele University of RomeWilliam H. Bradley - Medical College of WisconsinIlan Bruchim - Technion – Israel Institute of TechnologyK. Sun - TesaroIzabela A. Malinowska - TesaroY. Li - TesaroDivya GuptaBradley J. Monk - The US Oncology Network
- Publication Details
- International journal of gynecological cancer, Vol.29(Suppl 4), pp.González-Martín , A , Pothuri , B , Vergote , I , Christensen , R D , Graybill , W , Mirza , M R , McCormick , C , Lorusso , D , Hoskins , P , Freyer , G , Baumann , K , Jardon , K , Redondo , A , Moore , R G , Vulsteke , C , O'Cearbhaill , R E , Lund , B , Backes , F , Barretina-Ginesta , P , Haggerty , A F , Rubio-Pérez , M J , Shahin , M S , Mangili , G , Bradley , W H , Bruchim , I , Sun , K , Malinowska , I A , Li , Y , Gupta , D & Monk , B J 2019 , ' Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study ' , International Journal of Gynecological Cancer , vol. 29 , no. Suppl. 4 , pp. A9-A10 . https://doi.org/10.1136/ijgc-2019-ESGO.9-González-Martín , A , Pothuri , B , Vergote , I , Christensen , R D , Graybill , W , Mirza , M R , McCormick , C , Lorusso , D , Hoskins , P , Freyer , G , Baumann , K , Jardon , K , Redondo , A , Moore , R G , Vulsteke , C , O'Cearbhaill , R E , Lund , B , Backes , F , Barretina-Ginesta , P , Haggerty , A F , Rubio-Pérez , M J , Shahin , M S , Mangili , G , Bradley , W H , Bruchim , I , Sun , K , Malinowska , I A , Li , Y , Gupta , D & Monk , B J 2019 , ' Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study ' , International Journal of Gynecological Cancer , vol. 29 , no. Suppl. 4 , pp. A9-A10 . https://doi.org/10.1136/ijgc-2019-ESGO.9
- Identifiers
- 991005969157102656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study
International journal of gynecological cancer, Vol.29(Suppl 4), pp.González-Martín , A , Pothuri , B , Vergote , I , Christensen , R D , Graybill , W , Mirza , M R , McCormick , C , Lorusso , D , Hoskins , P , Freyer , G , Baumann , K , Jardon , K , Redondo , A , Moore , R G , Vulsteke , C , O'Cearbhaill , R E , Lund , B , Backes , F , Barretina-Ginesta , P , Haggerty , A F , Rubio-Pérez , M J , Shahin , M S , Mangili , G , Bradley , W H , Bruchim , I , Sun , K , Malinowska , I A , Li , Y , Gupta , D & Monk , B J 2019 , ' Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study ' , International Journal of Gynecological Cancer , vol. 29 , no. Suppl. 4 , pp. A9-A10 . https://doi.org/10.1136/ijgc-2019-ESGO.9-González-Martín , A , Pothuri , B , Vergote , I , Christensen , R D , Graybill , W , Mirza , M R , McCormick , C , Lorusso , D , Hoskins , P , Freyer , G , Baumann , K , Jardon , K , Redondo , A , Moore , R G , Vulsteke , C , O'Cearbhaill , R E , Lund , B , Backes , F , Barretina-Ginesta , P , Haggerty , A F , Rubio-Pérez , M J , Shahin , M S , Mangili , G , Bradley , W H , Bruchim , I , Sun , K , Malinowska , I A , Li , Y , Gupta , D & Monk , B J 2019 , ' Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study ' , International Journal of Gynecological Cancer , vol. 29 , no. Suppl. 4 , pp. A9-A10 . https://doi.org/10.1136/ijgc-2019-ESGO.9
11/01/2019
Metrics
3 Record Views